Cellular Biomedicine Group Calls for General Annual Stockholder Meeting on November 20, 2015
October 20 2015 - 9:00AM
Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the
“Company”), a biomedicine firm engaged in the development of
effective stem cell therapies for degenerative diseases and
immunotherapies for cancer, today announced that the Board of the
Company has set Friday, November 20, 2015 as the date for the
Company’s annual meeting of stockholders, to be held at the
Company’s office at 19925 Stevens Creek Blvd., Suite 100,
Cupertino, California 95014 at 9:00 a.m. PST, and any and all
adjournments or postponements thereof, and authorizes and instructs
the designated proxies to vote in the manner directed in the proxy
cards received for each stockholder of record as of September 21,
2015, the record date for the meeting.
A stockholder, once having received his/her proxy
notice and access card, may view the proxy statement online or
request a printed copy at www.iproxydirect.com/CBMG.
Stockholders may vote online, by mail or by phone, according to the
instructions on the proxy, no later than 11:59pm, Thursday,
November 19, 2015, EST. If your shares are held in the name of a
bank, broker or other nominee, please check with your bank, broker
or nominee and follow the voting instructions it provides. Please
send an email to sarah.kelly@CellBioMedGroup.com if you have
questions about this proxy voting or have not received your proxy
notice card in the mail.
About Cellular Biomedicine
GroupCellular Biomedicine Group, Inc. develops proprietary
cell therapies for the treatment of certain degenerative and
cancerous diseases. Our developmental stem cell and Immuno-Oncology
projects are the result of research and development by scientists
and doctors from China and the United States. Our
flagship GMP facility in China, consisting of six independent cell
production lines, is designed, certified and managed according to
U.S. standards. To learn more about CBMG, please visit:
www.cellbiomedgroup.com
Sarah Kelly
Director of Corporate Communications, CBMG
+1 408-973-7884
sarah.kelly@cellbiomedgroup.com
Vivian Chen
Managing Director Investor Relations, Grayling
+1 347 481-3711
vivian.chen@grayling.com
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cellular Biomedicine (NASDAQ:CBMG)
Historical Stock Chart
From Sep 2023 to Sep 2024